
Tianjin TEDA Biomedical Engineering Company Limited
8189.HKHKSEBasic MaterialsAgricultural Inputs
最新数据
HK$0.255
−HK$0.015 · -5.56%
8189.HK公司概览
盘中时间采用HKT。市场数据可能有所延迟。
公司概况
公司网站Tianjin TEDA Biomedical Engineering Company Limited, founded in 2000 and based in Tianjin, People's Republic of China, is a diversified enterprise primarily involved in the research, development, manufacturing, and distribution of biological compound fertilizer products throughout the PRC. Its operations are organized into two main divisions: Biological Compound Fertilizers and Elderly and Health Care Services. The company's agricultural offerings encompass active fertilizers and various tailored blends of nitrogen, phosphorus, and potassium, specifically formulated to promote balanced growth for a range of crops including grains, fruits, and vegetables. Beyond agriculture, Tianjin TEDA Biomedical provides integrated care for the elderly and comprehensive health services. This includes leasing essential equipment for seniors and offering specialized consulting, advisory, and assessment solutions. Furthermore, the company develops and licenses electroencephalography (EEG) diagnosis detection services, utilizing its expertise in EEG technology for diagnostic applications. Its extensive activities also cover the research, development, production, and practical application of biomedical science and technology projects, alongside regional soil resource conditioning and remediation, and the provision of soil environmental quality standards research services.
- 行业
- Agricultural Inputs
- 部门
- Basic Materials
- 总部
- CN
- 首席执行官
- Li Sun
- 上市以来
- 2002年6月18日
- 雇员
- 273
市场位置
日内区间
当前HK$0.255,
52周区间
当前HK$0.255,
- 开盘价
- HK$0.255
- 前收盘价
- HK$0.27
- 成交量
- 46.5万
- 0.68× 平均值
- 平均成交量
- 68.54万
- 日均成交量
- 市值
- 5.44亿 HKD
- 贝塔
- -0.44
- 市场参考 1
- 50天平均值
- HK$0.1618
- 高于平均水平+57.56%
- 200天平均值
- HK$0.2597
- 低于平均水平-1.81%
财务数据
财务快照
最近十二个月估值与收益率
- 企业价值
- 6.5亿 CNY
- 市盈率(TTM)
- -3.48×
- 市净率(TTM)
- 37.24×
- 市销率(TTM)
- 0.7×
- EV/EBITDA
- -45.41×
- 盈利收益率
- -15.53%
- 自由现金流收益率
- -11.03%
- 股息率
- 0.00%
盈利能力和效率
- 毛利率
- 5.22%
- 营业利润率
- -7.18%
- 净利润率
- -19.75%
- 净资产收益率
- -723.42%
- 资产收益率
- -33.39%
- 投入资本回报率
- -20.64%
财务健康
- 负债权益比
- 8.98×
- 流动比率
- 0.75×
- 奥特曼 Z 分数
- 0.02
- 皮奥特罗斯基 F 分数
- 4 共 9 个
财务报表
利润率趋势
盈利能力占已公布营收的百分比。
损益趋势
营收
营业利润
净利润
| 项目(CNY) | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 5.09亿 CNY | 3.85亿 CNY | 3.98亿 CNY | 4.04亿 CNY | 4.76亿 CNY |
| 销货成本 | 4.75亿 CNY | 3.69亿 CNY | 3.77亿 CNY | 4.33亿 CNY | 4.31亿 CNY |
| 毛利 | 3475.13万 CNY | 1696.96万 CNY | 2136.57万 CNY | 1482.23万 CNY | 4560.47万 CNY |
| 研究与开发 | 403.35万 CNY | 110.21万 CNY | 131.93万 CNY | 113.65万 CNY | 349.88万 CNY |
| 销售、一般及管理费用 | 3222.19万 CNY | 3426.19万 CNY | 2990.56万 CNY | 3748.88万 CNY | 4875.59万 CNY |
| 营业费用 | 5831.93万 CNY | 4535.41万 CNY | 3120.05万 CNY | 3851.09万 CNY | 6399.41万 CNY |
| 利息收入 | 7.56万 CNY | 4.8万 CNY | 25万 CNY | 76.28万 CNY | 43.08万 CNY |
| 利息支出 | 369.09万 CNY | 458.1万 CNY | 517.29万 CNY | 640.15万 CNY | 546.71万 CNY |
| 折旧和摊销 | 924.66万 CNY | 819.7万 CNY | 1163.36万 CNY | 1538.97万 CNY | 951.33万 CNY |
| 营业利润 | −2356.81万 CNY | −2838.45万 CNY | −983.49万 CNY | −2441.44万 CNY | −1838.94万 CNY |
| 净利润 | −8846.99万 CNY | −2780.22万 CNY | −2015.97万 CNY | −2745.15万 CNY | −4225.5万 CNY |
公司数据更新于 2026年8月24日。
财报历史与展望
- 最新每股收益结果
- -0
EPS:实际值与预期值
近期已公布业绩
营收:实际值与预期值
近期已公布业绩
8189.HK同业公司
继续GoAI的研究
在 GoAI 中研究8189.HKresearch.disclaimer





